SB
Samynathan Bhairavan
About Samynathan Bhairavan
Data last updated:
Samynathan Bhairavan has 9 years in corporate governance. Holds Director role. Currently with 2 companies, including Gp Pharmacare Private Limited and Maharaja Impex Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Maharaja Impex Private Limited at ₹12.96 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 02 Nov 2016 | 2007 | ₹12.96 Cr (FY 2025) | Active | |
| Director | 14 Mar 2023 | 2023 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Samynathan Bhairavan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Samynathan Bhairavan
Samynathan Bhairavan has 9 years in corporate governance. Holds Director role. Currently with 2 companies, including Gp Pharmacare Private Limited and Maharaja Impex Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Maharaja Impex Private Limited at ₹12.96 Cr (FY 2025).
Samynathan Bhairavan is associated with 2 companies as Director, including Maharaja Impex Private Limited (₹12.96 Cr), Gp Pharmacare Private Limited.
Samynathan Bhairavan has expertise in General Business.
Samynathan Bhairavan has 9 years in corporate governance.
By reported revenue, the largest current company of Samynathan Bhairavan is Maharaja Impex Private Limited, with revenue of ₹12.96 Cr (FY 2025).
Samynathan Bhairavan currently holds positions at 2 companies: Maharaja Impex Private Limited (₹12.96 Cr), Gp Pharmacare Private Limited.